News
GSK, RSV and EMA
Digest more
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a ...
Abrysvo has also been approved as a maternal vaccine to prevent RSV in newborns, an indication that GSK abandoned for Arexvy, but in that category it has to compete with Sanofi and AstraZeneca’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback